Complexes Cis Research Articles

Hydrosilylation of Alkynes Catalyzed by an Iron(II) PCP Pincer Alkyl Complex

Vinylsilanes are very useful building blocks in organic synthesis and have widespread applications in life sciences and materials chemistry. Here we describe the potential of complex cis‐[Fe(PCP‐iPr)(CH2CH2CH3)(CO)2] as an effective catalyst for the hydrosilylation of both terminal and internal alkynes with SiPhH3 to give vinylsilanes. The reactions were typically performed with a catalyst loading of 1 mol% for 24 h at 70oC. The catalytic reaction is initiated by migratory insertion of a CO ligand into the Fe‐alkyl bond to yield an acyl intermediate which reacts with silanes to form the 16e‐ Fe(II) silyl catalyst [Fe(PCP‐iPr)(SiPhH2)(CO)]. In the case of aliphatic terminal alkynes good regioselectivity (anti‐Markovnikov addition) towards the thermodynamically more stable β‐(E)‐vinylsilanes in ratios of up to 10:90 was achieved, while for aromatic alkynes the selectivities were poor with ratios of β‐(Z)‐ to β‐(E)‐vinylsilanes of about 40:60. With internal unsymmetrical alkynes, the two possible regioisomers of the syn‐addition of SiPhH3 were obtained in different ratios with no clear trend towards one regioisomer. Internal symmetrical alkynes yielded exclusively the respective syn‐products in high yields. Mechanistic investigations including deuterium labelling studies were undertaken to provide a reasonable reaction mechanism.

Synthesis, Structure, and Properties of Nontrivial Iridium(III) Complexes Based on Anthracene-Decorated Benzimidazole Ligand.

Reactions of iridium trichloride hydrate with bulky 2-(9-anthracenyl)-1-phenyl-benzimidazole (anbi) in the presence of N-donor ligands afforded a number of unique noncyclometalated complexes, while attempts to prepare a common μ-chloro-bridged bis-cyclometalated dimer systematically gave a monocyclometalated complex cis-[Ir(C,N-anbi)(N-anbi)Cl2] instead. The obtained complexes were characterized by 1H NMR, high-resolution mass spectrometry, single-crystal and powder X-ray diffraction, UV-vis spectroscopy, and cyclic voltammetry. The noncyclometalated complexes fac-[Ir(N-anbi)(N^N)Cl3)], where N^N are 4,4'-disubstituted 2,2'-bipyridines, are octahedral and contain the anthracene and 2,2'-bipyridine units in a close cofacial arrangement. These complexes were found to be exceptionally inert to the chloride ligand exchange even in the presence of silver triflate, forming a rare trinuclear Ir-μ-Cl3-Ag-μ-Cl3-Ir structure instead. In the monocyclometalated complex, the Ir(III) ion is pentacoordinated in a rare square-pyramidal geometry, where the bulky anthracene fragment is involved in the steric shielding of the metal center. This is in line with the results of gas-phase density functional theory calculations, demonstrating that the experimentally observed structure is energetically most preferable. The monocyclometalated complex is deeply colored due to intense charge-transfer absorption bands in the range 450-650 nm with ε = 2000-5000 M-1 cm-1, superior to the noncyclometalated complexes. The synthesis, structures, and properties of the new complexes are discussed in the context of the related mono-, bis-, and noncyclometalated iridium(III) compounds.

Alkene Isomerization Catalyzed by a Mn(I) Bisphosphine Borohydride Complex.

An additive-free manganese-catalyzed isomerization of terminal alkenes to internal alkenes is described. This reaction is implementing an inexpensive nonprecious metal catalyst. The most efficient catalyst is the borohydride complex cis-[Mn(dippe)(CO)2(κ2-BH4)]. This catalyst operates at room temperature, with a catalyst loading of 2.5 mol %. A variety of terminal alkenes is effectively and selectively transformed into the respective internal E-alkenes. Preliminary results show chain-walking isomerization at an elevated temperature. Mechanistic studies were carried out, including stoichiometric reactions and in situ NMR analysis. These experiments are flanked by computational studies. Based on these, the catalytic process is initiated by the liberation of "BH3" as a THF adduct. The catalytic process is initiated by double bond insertion into an M-H species, leading to an alkyl metal intermediate, followed by β-hydride elimination at the opposite position to afford the isomerization product.

Hydroboration of Terminal Alkynes Catalyzed by a Mn(I) Alkyl PCP Pincer Complex Following Two Diverging Pathways.

A stereo- and regioselective Mn(I)-catalyzed hydroboration of terminal alkynes with pinacolborane (HBPin) is described. The hydroboration reaction is highly Z-selective in the case of aryl alkynes and E-selective in the case of aliphatic alkynes. The reaction requires no additives or solvents and proceeds with a catalyst loading of 1 mol % at 50-70 °C. The most active precatalyst is the bench-stable alkyl Mn(I) complex cis-[Mn(PCP-iPr)(CO)2(CH2CH2CH3)]. The catalytic process is initiated by the migratory insertion of a CO ligand into the Mn-alkyl bond to yield an acyl intermediate. This species undergoes C-H and B-H bond cleavage of the alkyne (aromatic alkynes) and HBPin (in the case of aliphatic alkynes) forming the active Mn(I) alkynyl and boryl catalysts [Mn(PCP-iPr)(CO)(C≡CR)] and [Mn(PCP-iPr)(CO)(BPin)], respectively. A broad variety of aromatic and aliphatic alkynes was efficiently and selectively borylated. Mechanistic insights are provided based on experimental data and DFT calculations. The functionalized alkenes can be used for further applications in cross-coupling reactions.

Oxidative-addition of tetramethylthiuram disulfide (Me4TDS) and monosulfide (Me4TMS) at a triosmium centre: Generation of dithiocarbamate, trithiocarbamate, thiocarboxamide and amino-carbyne ligands

Thermolytic reactions of [Os3(CO)12] with tetramethylthiuram disulfide (Me4TDS) and tetramethylthiuram monosulfide (Me4TMS) are described. While both afford the anticipated bis(dithiocarbamate) complex cis-[Os(CO)2(S2CNMe2)2] (1) as the major product, unexpected secondary products result in both cases. With Me4TDS this is the trithiocarbamate-dithiocarbamate complex cis-[Os(CO)2(S2CNMe2)(S3CNMe2)] (2) resulting (formally) from sulfur insertion into an Os-S bond. Heating 1 with further Me4TDS did afford 2, albeit in small amounts and on a timeframe incompatible with its formation under the initial reaction conditions. From the Me4TMS reaction, binuclear [Os2(CO)3(S2CNMe2)2(µ-CNMe2)(µ-SCNMe2)] (3) is a secondary product. It contains dithiocarbamate, thiocarboxamide and amino-carbyne ligands, the last two resulting (formally) from the oxidative addition of a C-S bond in Me4TMS. Both new complexes have been characterised by X-ray crystallography.

Activation of SO2F2 at a Rhodium PNP Pincer Complex: Ligand Supported S-F Bond Cleavage to Generate NSO2F Derivatives.

The κ2-(P,N)-phosphine ligand precursor NH(CH2CH2PCy2)2 can be used for the synthesis of the rhodium(I) complex [Rh(CO){ĸ3-(P,N,P)-Cy2PC2H4NHC2H4PCy2}][Cl] (1). The deprotonated complex [Rh(CO){ĸ3-(P,N,P)-Cy2PC2H4NC2H4PCy2}] (2) shows a cooperative reactivity of the PNP ligand in the activation reaction of SO2F2 to yield the rhodium fluorido complex trans-[Rh(F)(CO){ĸ2-(P,P)-Cy2PC2H4N(SO2F)C2H4PCy2}]2 (3) by S-F bond cleavage. It is remarkable that no reaction was observed when 3 was treated with hydrogen sources e. g. dihydrogen, organosilicon compounds such as triethylsilane or TMS-CF3 and different fluorine sources such as SF4 or Selectfluor®. However, the treatment of complex 3 with XeF2 in the presence of CsF resulted in the formation of the unique fluorido rhodium(III) complex cis,trans-[Rh(F)3(CO){ĸ2-(P,P)-Cy2PC2H4N(SO2F)C2H4PCy2}]2 (4). In the presence of pyridine(HF)X or BF3 the fluorido complex 3 converted into the dicationic complexes [Rh(CO){ĸ2-(P,P)-Cy2PC2H4N(SO2F)C2H4PCy2}]2[XF]2, X=HF (5) or BF3 (6), respectively.

The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone.

Monofunctional platinum complexes offer a promising alternative to cisplatin in cancer chemotherapy, showing a unique mechanism of action. Their ability to induce minor helix distortions effectively inhibits DNA transcription. In our study, we synthesized and characterized three monofunctional Pt(II) complexes with the general formula [Pt(en)(L)Cl]NO3, where en = ethylenediamine, and L = pyridine (py), 2-methylpyridine (2-mepy), and 2-phenylpyridine (2-phpy). The hydrolysis rates of [Pt(en)(py)Cl]NO3 (1) and [Pt(en)(2-mepy)Cl]NO3 (2) decrease with the bulkiness of the auxiliary ligand with k(1) = 2.28 ± 0.15 × 10-4 s-1 and k(2) = 8.69 ± 0.98 × 10-5 s-1 at 298 K. The complex [Pt(en)(2-phpy)Cl]Cl (3) demonstrated distinct behavior. Upon hydrolysis, an equilibrium (Keq = 0.385 mM) between the complexes [Pt(en)(2-phpy)Cl]+ and [Pt(en)(2-phpy-H+)]+ was observed with no evidence (NMR or HR-ESI-MS) for the presence of the aquated complex [Pt(en)(2-phpy)(H2O)]2+. Despite the kinetic similarities between phenanthriplatin and (2), complexes (1) and (2) exhibit minimal activity against A549 lung cancer cell line (IC50 > 100 μΜ), whereas complex (3) exhibits notable cytotoxicity (IC50 = 41.11 ± 2.1 μΜ). In examining the DNA binding of (1) and (2) to the DNA model guanosine (guo), we validated their binding through guoN7, which led to an increased population of the C3'-endo sugar conformation, as expected. However, we observed that the rapid transition 2E (C2'-endo) ↔ 3E (C3'-endo), in the case of [Pt(en)(py)(guo)](NO3)2 ([1-guo]), slows down in the case of [Pt(en)(2-mepy)(guo)](NO3)2 ([2-guo]), resulting in separate signals for the two conformers in the 1H NMR spectra. This phenomenon arises from the steric hindrance between the methyl group of pyridine and the sugar moiety of guanosine. Notably, this hindrance is absent in [2-(9-MeG)] (9-MeG = 9-methylguanine), probably due to the absence of a bulky sugar unit in 9-MeG. In the case of (3), where the bulkiness of the substitution on the pyridine is further increased by a phenyl group, we observed a notable proximity between 9-MeGH8 and the phenyl ring of 2-phpy. Considering that only (3) exhibited good cytotoxicity against the A549 cancer cell line, it is suggested that auxiliary ligands, L, with an extended aromatic system and proper orientation in complexes of the type cis-[Pt(en)(L)Cl]NO3, may enhance the cytotoxic activity of such complexes.

The Effect of Weakly Coordinating Solvent and Counter Anion on Diphosphine‐Palladium(II) Catalytic Reactivity for Copolymerization of 1‐Butene with Carbon Monoxide in Aqueous Media

AbstractWater soluble bis(acetonitrile) diphospalladium (II) complexes cis‐[Pd(L1–L5)(NCCH3)2][BF4]2 (C1–C5) were obtained by the reaction [Pd(NCCH3)4][BF4]2 with diphosphines ligands L1–L5 (CH2(CH2PR2)2: where R=(CH2)nP(O)(OEt)2, n=2–4, n=6 and n=8)) in dichloromethane–acetonitrile. The isolated complexes were characterized by elemental analysis, FTIR, 1H‐ and 31P‐NMR spectroscopy. The complexes were applied as catalysts for the copolymerization of 1‐butene with carbon monoxide in aqueous media. The present work emphasized on the effect of weakly coordinated solvent and counterion on the catalytic behavior of cis‐[Pd(L1–L5)(NCCH3)2][BF4]2 complexes compared to previously prepared cis‐[ Pd(L1–L5)(OAc)2] (A1–A5). The exchange of π‐bonding NCCH3 ligand with π‐bonding CO and alkene was more favored than the exchange of σ‐bonding OAc− as reflected by the much higher catalytic activity (TON) of the former compared to the latter. In order to compare the catalytic efficiency of water soluble complexes with the performance of a standard, the water insoluble complex, cis‐[Pd(CH2(CH2P(CH2CH3)2)2(NCCH3)2][BF4]2, C6, was prepared and incorporated in the investigations. The isolated alternating 1‐butene/CO copolymer exhibits glass transition temperature of Tg=−3–−15 °C, which is in the range desirable for latex emulsion application. The solid content is up to 21 % with high molecular weight (Mw=4×104 g mol−1) and narrow polydispersities (Mw/Mn=2–3). The C5 complex was found to be fourteen times more active in aqueous polymerization medium (6369 mol substr. mol Pd−1 h−1) than C6 complex in nonaqueous medium (441 mol substr. mol Pd−1 h−1).

A novel Pt2+ complex containing 1,4-benzodioxan-6-amine: Stability, DNA binding, and antitumor effects against human breast cancer cells

In this work, a new platinum(II) complex was prepared by the reaction of K2PtCl4 with 1,4-benzodioxan-6-amine (bda) at room temperature in the molar ratio 2:1 (L:M). The complex was characterized by physicochemical (elemental analysis, TGA/DTA, and conductivity measurements) and spectroscopic methods (UV–Vis, FTIR, 1H, 13C and 195Pt NMR). According to the spectroscopic data, two bda ligands coordinate to the platinum ion in a monodentate manner through the nitrogen atom to give the complex cis-[PtCl2(bda)2]. Stability studies were carried out under different conditions and showed that the complex is stable in pure DMF, although it undergoes slow solvolysis in DMSO. The interaction of this complex with calf thymus DNA (CT-DNA) was studied using circular dichroism (CD), electronic absorption and fluorescence spectroscopy. The complex binds to CT-DNA with a Kb value of 1.06 ​× ​103 ​M−1 and according to data from CD and fluorescence spectroscopy, appears to interact with DNA by electrostatic forces and or other no intercalative binding mode. Compared to cisplatin, the complex exhibited good cytotoxic activity and selectivity against the MCF-7 tumor cell line, displaying an IC50 value of 17.33 ​± ​1.1 ​μM, as well as inhibited MCF-7 ​cells migration.

Thiosalicylanilide complexes of nickel(II), palladium(II) and platinum(II)

Reactions of the complexes cis-[PtCl2(PPh3)2], [PtCl2(dppf)] {dppf = Fe(C5H4PPh2)2}, [PdCl2(PPh3)2], [PdCl2(dppe)] (dppe = Ph2PCH2CH2PPh2) and [NiCl2(dppe)] with thiosalicylanilide (HSC6H4CONHPh, H2-1a) and its substituted derivatives H2-1b to H2-1d (where H2-1b = p-Cl-HSC6H4CONHPh, H2-1c = p-CH3-HSC6H4CONHPh, and H2-1d = m-OCH3-HSC6H4CONHPh) gave a series of square-planar MS2P2-type complexes. The complexes were characterised by ESI MS, 1H and 31P{1H} NMR, FTIR, and microelemental analyses, and in some cases by single crystal X-ray crystallography. The predominant coordination mode is through bonding of deprotonated thiol group of two ligands. However, the tendency to form complexes with a single, chelating S,N- and S,O-donor ligand was observed by 31P{1H} NMR in some reactions. In addition, cis/trans isomerisation was observed in some complexes by 31P{1H} NMR and confirmed by X-ray structure determinations on trans-[Pt(H-1b)2(PPh3)2] and trans-[Pd(H-1b)2(PPh3)2]. A comparison of the energetics of the reaction systems involving [Pt(1b)(PPh3)2]/[Pt(H-1b)2(PPh3)2], [Pt(1d)(PPh3)2]/[Pt(H-1d)2(PPh3)2] and [Pd(1b)(dppe)]/[Pd(H-1b)2(dppe)] using Density Functional Theory (DFT) revealed that the MS2P2 systems [Pt(H-1b)2(PPh3)2], [Pt(H-1d)2(PPh3)2] and [Pd(H-1b)2(dppe)] have lower Gibbs free energies than the S,N-chelate systems [Pt(1b)(PPh3)2], [Pt(1d)(PPh3)2] and [Pd(1b)(dppe)], and are thermodynamically favoured. Intermolecular interactions quantified and visualized on Hirshfeld surfaces for trans-[Pt(H-1b)2(PPh3)2], [Pt(H-1d)2(PPh3)2].H2O, and [Pd(H-1a)2(dppe)] revealed the dominant contribution of H···H contacts to crystal packing.

Novel Ruthenium‐based Nitrosyl Complexes: NO Donation and Vasorelaxant Potentials for Cardiovascular Therapeutics

AbstractNitrosyl ruthenium complexes have emerged as promising platforms for the controlled delivery of nitric oxide (NO) and nitroxyl (HNO), both of which possess significant therapeutic implications. Considering this scenario, we synthesized and characterized the metal complex cis‐[RuNO(phen)2(2MIM)]3+ and its precursors, where phen and 2MIM correspond to 1,10‐phenantroline and 2‐methylimidazole, respectively. Comprehensive structural elucidation was undertaken using a combination of spectroscopic and electrochemical methodologies, including XANES/EXAFS experiments. This structural data was further validated through DFT computational analyses. We demonstrated that such compound can release NO and HNO in the presence of thiol‐based substrates. Not only this, but the same metal complex can also delivery nitric oxide under irradiation with visible light (λ=460 nm). The nitrosyl complex and its derivatives displayed marked vasodilatory capabilities as evidenced in assays involving isolated rat aorta rings. They also exhibited commendable antioxidant activity in free radical scavenging assays. Collectively, based on these data, this nitrosyl ruthenium compound is a potential therapeutic candidate, especially in the field of cardiovascular pathology like atherosclerosis, thereby deserving further in‐depth investigations.

Reduction of CO to Methanol with Recyclable Organic Hydrides.

The reaction steps for the selective conversion of a transition metal carbonyl complex to a hydroxymethyl complex that releases methanol upon irradiation with visible light have been successfully quantified in acetonitrile solution with dihydrobenzimidazole organic hydride reductants. Dihydrobenzimidazole reductants have been shown to be inactive toward H2 generation in the presence of a wide range of proton sources and have been regenerated electrochemically or photochemically. Specifically, the reaction of cis-[Ru(bpy)2(CO)2]2+ (bpy = 2,2'-bipyridine) with one equivalent of a dihydrobenzimidazole quantitatively yields a formyl complex, cis-[Ru(bpy)2(CO)(CHO)]+, and the corresponding benzimidazolium on a seconds time scale. Kinetic experiments revealed a first-order dependence on the benzimidazole hydride concentration and an unusually large kinetic isotope effect, inconsistent with direct hydride transfer and more likely to occur by an electron transfer-proton-coupled electron transfer (EΤ-PCET) or related mechanism. Further reduction/protonation of cis-[Ru(bpy)2(CO)(CHO)]+ with two equivalents of the organic hydride yields the hydroxymethyl complex cis-[Ru(bpy)2(CO)(CH2OH)]+. Visible light excitation of cis-[Ru(bpy)2(CO)(CH2OH)]+ in the presence of excess organic hydride was shown to yield free methanol. Identification and quantification of methanol as the sole CO reduction product was confirmed by 1H NMR spectroscopy and gas chromatography. The high selectivity and mild reaction conditions suggest a viable approach for methanol production from CO, and from CO2 through cascade catalysis, with renewable organic hydrides that bear similarities to Nature's NADPH/NADP+.

Iridium(I) 1,3,4,4‐Tetraamino‐1,2‐cyclobutadiene Complexes

AbstractThe dimer of dipiperidinoacetylene, 1,3,4,4‐tetrapiperidino‐3‐buten‐1‐yne, reacts with [IrCl(COD)]2 (COD=1,5‐cyclooctadiene) to give the corresponding 1,3,4,4‐tetrapiperidino‐1,2‐cyclobutadiene‐iridium complex [(CBA)IrCl(COD)] with a four‐membered cyclic bent allene (CBA) ligand. Reaction with carbon monoxide affords the dicarbonyl complex cis‐[(CBA)IrCl(CO)2], which exhibits low CO stretching frequencies and an associated Tolman electronic parameter (TEP) value of 2030 cm−1, which is lower than any other TEP value reported for cyclic carbene and carbenoid ligand systems. Treatment of [(CBA)IrCl(COD)] with sodium tetrakis[3,5‐bis(trifluoromethyl)phenyl]borate (NaBARF) followed by addition of phosphines or pyridine (py) yields the cationic complexes [(CBA)IrL(COD)][BARF] (L=PPh3, PPh2Me, PPhMe2, PCy3, py) as potential hydrogen isotope exchange (HIE) catalysts. DFT calculations provide evidence for a suitable pathway for the cyclization of 1,3,4,4‐tetrapiperidino‐3‐buten‐1‐yne at transition metal complex fragments, here AuCl, IrCl(COD), and IrCl(CO)2, as a general route to four‐membered CBA metal complexes.

Synthesis, structure and physicochemical properties of the boron rich PtII complexes [(CN)2dppPtCl(CBT)] and [(CN)2dppPt(CBT)2] (CBT = m-carborane-1-thiolate)

The present report deals with the synthesis of the two PtII complexes of respective formula cis-[(CN)2dppPtCl(CBT)]ˑ0.5(CH3)2CO and cis-[(CN)2dppPt(CBT)2] (dpp = 2,3-di(2-pyridyl)pyrazine; CBT = m-carborane-1-thiolate anion) the structure of both of them elucidated by single-crystal X-ray work and further examined by IR spectral behavior. These “low-molecular weight” mono- and bis-CBT derivatives may represent members of the restricted area of potential anticancer agents in BNCT (boron neutron capture therapy). Although insoluble in water, these new species are enough soluble in organic low-donor solvents like DMSO, CH3CN, THF, and solution studies in these solvents have allowed their physicochemical characterization by UV–visible and NMR measurements. Of relevant interest is the observed absorption present in the UV–visible spectrum of both species in the three solvents positioned in the region 400–500 nm, intimately related to the presence of CBT in both the cis-arranged species, similarly to what observed in previously published strictly related analogs.

Antimony centre in three different roles: does donor strength or acceptor ability determine the bonding pattern?

A set of antimony(III) compounds containing a ligand (Ar) with a pendant guanidine function (where Ar = 2-[(Me2N)2CN]C6H4) was prepared and characterized. This includes triorgano-Ar3Sb, diorgano-Ar2SbCl and monoorgano-ArSbCl2 compounds and they were characterized by 1H and 13C NMR spectroscopy and by single-crystal X-ray diffraction analysis (sc-XRD). The coordination capability of Ar3Sb and Ar2SbCl was examined in the reactions with either cis-[PdCl2(CH3CN)2] or PtCl2 and complexes cis-[(κ2-Sb,N-Ar3Sb)MCl2] (M = Pd 1, Pt 2) and [(κ3-N,Sb,N-Ar2SbCl)MCl2] (M = Pd 3, Pt 4) were isolated, while their structures were determined by sc-XRD. Notably, the ligands Ar3Sb and Ar2SbCl exhibit different coordination modes - bidentate and tridentate, respectively - and the antimony exhibits three distinct bonding modes in complexes 1-4, which were also subjected to theoretical studies.

Deciphering the sub-Golgi localization of glycosyltransferases via 3D super-resolution imaging.

The Golgi apparatus, a crucial organelle involved in protein processing, including glycosylation, exhibits complex sub-structures, i.e., cis-, medial, and trans-cisternae. This study investigated the distribution of glycosyltransferases within the Golgi apparatus of mammalian cells via 3D super-resolution imaging. Focusing on human glycosyltransferases involved in N-glycan modification, we found that even enzymes presumed to coexist in the same Golgi compartment exhibit nuanced variations in localization. By artificially making their N-terminal regions [composed of a cytoplasmic, transmembrane, and stem segment (CTS)] identical, it was possible to enhance the degree of their colocalization, suggesting the decisive role of this region in determining the sub-Golgi localization of enzymes. Ultimately, this study reveals the molecular codes within CTS regions as key determinants of glycosyltransferase localization, providing insights into precise control over the positioning of glycosyltransferases, and consequently, the interactions between glycosyltransferases and substrate glycoproteins as cargoes in the secretory pathway. This study advances our understanding of Golgi organization and opens avenues for programming the glycosylation of proteins for clinical applications.Key words: Golgi apparatus, glycosyltransferase, 3D super-resolution imaging, N-glycosylation.

Synthesis and characterization of cis and trans cobalt(II) nalidixate complexes having a 1-(4-chlorophenyl)-3-(pyridin-4-ylmethyl)urea ligand.

The synthesis and characterization of specific cis- and trans-isomers of a cobalt(II) bis-nalidixate complex with a pyridine-based urea, 1-(4-chlorophenyl)-3-(pyridin-4-ylmethyl)urea (L), ligand are reported. The two isomers, cis-[Co(L)2(NALD)2]·0.5DMF·H2O and trans-[Co(L)2(NALD)2]·2DMF·2H2O (the nalidixate anion is abbreviated to NALD) were prepared by anion-guided synthesis. When cobalt(II) chloride was used as one of the reactants, the reaction yielded the trans-isomer under ambient reaction conditions. Whereas a reaction using cobalt(II) nitrate provided only the cis-isomer when the reaction was continued for a prolonged time. On the other hand, the cis-isomer was converted to the trans-isomer in solution upon treatment with chloride ions. The chloride-assisted formation of the trans-isomer was investigated by a UV-visible study, and it passed through a bond reorganization by forming a tetrahedral intermediate complex. A DFT calculation was carried out to show the difference in energy between the isomers as well as the energy of a plausible tetrahedral cobalt complex. The aggregation behavior of the cis-isomer in different solvents was investigated, and solvent-dependent aggregation and a solvent-dependent Cotton effect were observed.

Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells.

Glioblastoma multiforme (GBM) is the most common highly aggressive malignant brain tumor, with a very limited chance for survival post-diagnosis and post-treatment. Despite significant advancement in GBM genomics implicated in molecularly targeted chemotherapies, the prognosis remains poor and requires new drug discovery approaches. We used fluoropyrimidine 5-fluorouracil (5-FU), an antimetabolite anticancer drug conjugated or 'caged' within a lipophilic Ru(II)-diphosphine (dppe) core formulated as [RuII(dppe)2(5-FU)]PF6 (Ru-DPPE-5FU), where dppe = 1,2-bis(diphenylphosphino)ethane, and evaluated its in vitro cytotoxicity in depth with aggressive GBM cells (LN229). The hydrophilic nature of 5-FU limits its passage through the blood-brain barrier (BBB), which prevents its effective accumulation and efficacy for GBM tumors. Herein, we attempted to modulate the lipophilicity of 5-FU by inserting it within a well-designed lipophilic {Ru(dppe)2}-core with anticipated higher efficiency towards GBM. The physicochemical properties of [RuII(dppe)2(5-FU)]PF6 (Ru-DPPE-5FU) were studied using various spectroscopic and analytical techniques. The molecular structure was determined using X-ray crystallography, showing a distorted {RuP4NO} octahedral geometry with bidentate (N, O) binding of 5-FU and its aromatization in the Ru(II)-bound form. The 31P-NMR spectra of Ru-DPPE-5FU showed four closely spaced distinct 31P-signals, indicating four unique chemical environments around P, and the strong coupling constants between them make it a second-order spectrum. The RuII/RuIII redox potential in Ru-DPPE-5FU shifted by ∼0.91 V towards the anodic region as compared to its precursor complex cis-[Ru(dppe)2Cl2] (Ru-DPPE-Cl). DFT-based theoretical calculations have been performed to correlate the experimental electronic absorption spectra and redox behaviours of the complexes. The electrostatic potential (ESP) plots indicate the delocalization of the charge density on the O-/F-atom from the 5-FU ligand towards Ru(II) upon its complexation. The antioxidant properties of all the compounds were quantified by a 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. The hyphenation of the 5-fluorouracil (5-FU) ligand to the lipophilic {Ru(dppe)2}-core endowed lipophilicity to Ru-DPPE-5FU with higher in vitro cytotoxicity (IC50 = 2.37 μM) against the LN229 GBM cells as compared to the hydrophilic 5-FU, suggesting efficient cellular uptake. Further biological assays indicated that the complex is highly potent in inhibiting significant proliferation and spheroid formation and restricting the migratory potentials of the GBM cells. Increased caspase 3/7 activity and the presence of apoptotic bodies at the center of 3-D GBM spheroids as revealed by AO/EB dual staining indicated a deeper penetration of the lipophilic complex. The Ru-DPPE-5FU complex displayed lower cytotoxicity in HaCaT normal cells (IC50 = 7.27 μM) in comparison to LN229 cancer cells with a selectivity index (S.I.) of ≥3. Overall, the synergism and caging of 5-FU within the hydrophobic {Ru(dppe)2}-core improves the pharmacokinetic profile of Ru-DPPE-5FU as a potent anticancer agent for glioblastoma.

Natural Essential Oils: A Promising Therapy Way for Treating Ischemic Stroke.

Stroke is an acute cerebrovascular disease with high morbidity, mortality, and disability, making it the second leading cause of death worldwide. Ischemic stroke (IS) accounts for the majority of strokes, and its pathogenesis is complex, often involving complications and sequelae. Currently, conventional clinical approaches are ineffective, with few drugs available for intravenous thrombolysis and mechanical thrombolysis limited by a short time window. With the poor efficacy of monotherapy, the search for new complementary or alternative therapies has become the focus of researchers. In traditional medicine, Chinese aromatherapy has a long history of using aromatic medicines to treat IS. Natural essential oils (EOs), as the main pharmacological substances in aromatic drugs, are composed of different ratios of active metabolites with multi-targets and multi-components, which makes EOs have a wide range of pharmacological effects. Modern studies have also shown that EOs extracts and isolated monomers are beneficial for pathologically complex CIS. Therefore, this paper summarizes the EOs and monomers obtained from EOs that can prevent and treat IS in the last 20 years, and finds that EOs exert their anti-CIS effects mainly through anti-oxidative stress, anti-inflammation, anti-apoptosis, and inhibition of excitotoxicity. The amelioration of IS complications by natural EOs and their active monomer components for the treatment of IS are further discussed.

Chalcogen bond stabilisation of platinum(II) sulfonyl-substituted thiourea complexes with ancillary phosphine ligands

A series of sulfonyl-substituted thiourea platinum(II) complexes bearing ancillary phosphine ligands were prepared by the reaction between cis-[PtCl2(PR3)2] (PR3 = triphenylphosphine, tris(2-cyanoethyl)phosphine and 1,3,5-triaza-7-phosphaadamantane) and either p-TolSO2NHC(S)NHPh or EtSO2NHC(S)NHPh, in a refluxing Et3N/methanol mixture. The mixed ligand complexes, bearing a single phosphine and pyridine, were also prepared by the reactions between cis-[PtCl2(COD)] (COD = cyclooctadiene), pyridine and p-TolSO2NHC(S)NHPh or EtSO2NHC(S)NHPh. For each complex, the thiourea ligand binds as a dianion through the S and NPh groups in the distal isomer with a remote NSO2R group. Only in the case of the reaction between the complex cis-[PtCl2(PPh3)2] and TolSO2NHC(S)NHCH(CH3)3) was the proximal isomer formed on account of the bulky t-butyl substituent on the thiourea. X-ray structures and computational analysis revealed another reason for this preferential distal isomer formation is most likely due to the presence of a stabilising chalcogen bond, which is otherwise unavailable in the proximal isomer.